XML 79 R69.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue Recognition - Disaggregation of Revenue (Details) - Revenue from Contract with Customer Benchmark - Product Concentration Risk
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Cell Engineering        
Disaggregation of Revenue [Line Items]        
Total 100.00% 100.00% 100.00% 100.00%
Pharma and biotech        
Disaggregation of Revenue [Line Items]        
Total 30.00% 33.00% 33.00% 21.00%
Agriculture        
Disaggregation of Revenue [Line Items]        
Total 22.00% 3.00% 23.00% 4.00%
Consumer and technology        
Disaggregation of Revenue [Line Items]        
Total 2.00% 28.00% 9.00% 44.00%
Food and nutrition        
Disaggregation of Revenue [Line Items]        
Total 24.00% 17.00% 17.00% 11.00%
Industrial and environment        
Disaggregation of Revenue [Line Items]        
Total 16.00% 15.00% 13.00% 16.00%
Government and defense        
Disaggregation of Revenue [Line Items]        
Total 6.00% 4.00% 5.00% 4.00%